Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2016-03-22 M&A Activity
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
aap Implantate AG: aap sells biomaterials business for EUR 36 million and becomes a pure player in trauma with innovative technologies
M&A Activity Classification · 99% confidence The document is an 'Ad-hoc Announcement' disseminated according to § 15 WpHG (German Securities Trading Act). It details a significant corporate action: the sale of a subsidiary (biomaterials business) for EUR 36 million, which impacts the company's strategy (becoming a pure trauma player) and requires an adjustment to the 2016 guidance. It also announces a postponement of the 2015 consolidated and annual financial statements publication due to the required accounting treatment of the discontinued operation. This type of material, announcing major strategic changes, asset disposals, and subsequent guidance revisions, falls under significant corporate events. Since it is not a full financial report (10-K, IR), a specific earnings release (ER), or a management discussion (MDA), and it relates to a major transaction/change in structure, the most fitting category is Capital/Financing Update (CAP) as it involves a major asset sale and subsequent capital/guidance implications, or potentially Regulatory Filings (RNS) as a general catch-all for ad-hoc disclosures. Given the focus on the disposal and the resulting strategic shift, 'CAP' is plausible, but 'RNS' is often used for general ad-hoc disclosures that don't fit the specific financial report types. However, the core event is a major transaction (disposal) affecting capital structure and future outlook. Since 'TAR' is for M&A (Takeover/Merger), and this is a divestiture, 'CAP' (Capital/Financing Update) is a strong candidate for major asset sales impacting financing/structure. Given the nature of the announcement (Ad-hoc disclosure of a major transaction and guidance change), and lacking a more specific category for 'Divestiture Announcement', RNS (Regulatory Filings) serves as the appropriate fallback for non-standard, mandatory disclosures, especially since it's an Ad-hoc release via DGAP. I will classify it as RNS as it is a general regulatory announcement of a material event.
2016-03-22 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document explicitly states 'Directors’ Dealings' in the title and header. The content details a transaction ('Purchase') by a person in a managerial role ('Position: Member of a managing body') concerning the company's stock, which perfectly matches the definition for Director's Dealing (DIRS). The reference to section 15a of the WpHG further confirms this regulatory filing type related to insider transactions.
2015-12-18 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managerial role ("Position: Member of a managing body"). The content describes the purchase of common bearer stock by 'Bruke Seyoum Alemu' on '26.11.2015'. This directly matches the definition for Director's Dealing (DIRS). The document is a formal notification regarding insider transactions.
2015-11-26 English
Release of the Home Member State according to Article 2c of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Regulatory Filings Classification · 98% confidence The document is very short (1222 characters) and its primary function is to announce a specific regulatory status update: the designation of Germany as the 'Home Member State' according to Article 2c of the WpHG (German Securities Trading Act). It explicitly states it is a 'Post-admission Duties announcement' transmitted by DGAP. This type of specific, non-financial, regulatory status update does not fit well into the core categories like 10-K, ER, or IR. Since it is a specific regulatory disclosure that doesn't match other defined categories (like DIRS, DIV, MANG, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it is a general regulatory announcement.
2015-11-26 English
Datum:13.11.2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quartalsbericht' (Quarterly Report) for Q3 2015 for 'aap Implantate AG'. It contains detailed financial tables (Umsatz, EBITDA, EBIT, Cash-Flow, Balance Sheet), management commentary (Vorwort des Vorstandes), and operational performance analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2015
2015-11-13 German
Q3 Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a '9-Month Report' for the period ending September 30, 2015. It contains detailed financial statements, including a consolidated balance sheet, statement of comprehensive income, cash flow statement, and notes to the interim consolidated financial statements. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2015
2015-11-13 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.